Trials / Completed
CompletedNCT01205750
Hepatic Insulin Sensitivity and Very Low Density Lipoprotein Triglyceride (VLDL-TG) Kinetics
Basal and Insulin Mediated VLDL-triglyceride Kinetics in Obesity; Relationship With Hepatic Insulin Sensitivity
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- Male
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Obesity is associated with dyslipidemia, which is a major risk factor for coronary heart disease. Triglycerides (TG) and cholesterol are transported in the system of lipoproteins, and the metabolism of these lipids in plasma is closely interrelated. Evidence suggests that increased concentration of very low-density lipoprotein triglyceride (VLDL-TG) is a central pathophysiological feature of the lipid and lipoprotein abnormalities in dyslipidemia. The primary objective of this study is to investigate VLDL-TG kinetics and hepatic insulin sensitivity in age-matched obese and lean, healthy men in the postabsorptive state and during acute hyperinsulinemia using VLDL-TG and glucose tracers.
Detailed description
Extensive description not included.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Glucose clamp | 450 min hyperinsulinemic euglycemic glucose clamp, 0,5 mU / kg lean body mass / min |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2010-09-20
- Last updated
- 2011-06-17
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01205750. Inclusion in this directory is not an endorsement.